The Priority Review

Tag

ZANVASTRO

1 story

  1. Regulation

    FDA issues priority review voucher for ZANVASTRO

    FDA approved ZANVASTRO on September 3, 2026. FDA issued a priority review voucher to the sponsor, Ionis Pharmaceuticals, Inc., after determining the product meets the criteria under the FD&C Act.